Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.71 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.71 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.67 |
| ▸ | MAPT | P10636 | 6/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.62 |
| ▸ | NPC1 | O15118 | 3/20 | 0.62 |
| ▸ | RAB9A | P51151 | 3/20 | 0.62 |
| ▸ | LMNA | P02545 | 4/20 | 0.61 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | HTT | P42858 | 3/20 | 0.54 |
| ▸ | HPGD | P15428 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.54 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7952282 | 0.84 | SIRT2 (0.72) | SIRT2MAPTL3MBTL1NPC1RAB9A | |
| Oxolamine SCHEMBL893333 | 0.83 | HTR1A (1.00) | HTR1AHRH3MAPTL3MBTL1NPC1 | |
| Oxolamine SCHEMBL1652318 | 0.82 | HTR1A (0.97) | HTR1AHRH3MAPTL3MBTL1NPC1 | |
| SCHEMBL7148635 | 0.80 | SIRT2 (0.70) | SIRT2MAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL14788168 | 0.80 | SIRT2 (0.74) | SIRT2MAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL27034989 | 0.80 | ALDH1A1 (0.68) | SIRT2MAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL3265992 | 0.80 | SIRT2 (0.73) | SIRT2MAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL7296066 | 0.78 | SIRT2 (0.75) | SIRT2MAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL27035148 | 0.77 | ALDH1A1 (0.65) | SIRT2MAPTL3MBTL1NPC1RAB9A | |
| SCHEMBL17513948 | 0.77 | SIRT2 (0.65) | SIRT2MAPTL3MBTL1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 816 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122036828-A | Nucleotide analogue, kit and application | 深圳赛陆医疗科技有限公司 | 2026-05-15 | — | — | CN | claimed |
| CN-122012683-A | Gene sequencing method and kit | 深圳赛陆医疗科技有限公司 | 2026-05-12 | — | — | CN | claimed |
| US-12545746-B2 | Anti-BCMA car antibodies, conjugates, and methods of use | 2SEVENTY BIO, INC. (US) | 2026-02-10 | — | — | US | claimed |
| EP-4684006-A1 | ASSAYS FOR CHARACTERIZATION OF EXTRACELLULAR VESICLES AND METHODS OF USING THE SAME | The Translational Genomics Research Institute (US) | 2026-01-28 | — | — | EP | claimed |
| WO-2025245370-A1 | FLUORESCENCE-BASED DETECTION METHODS, COMPOUND PANELS, AND ARRAYS INCLUDING THE SAME FOR FLUORESCENCE DETECTION | ALBERT EINSTEIN COLLEGE OF MEDICINE (US) | 2025-11-27 | — | — | WO | claimed |
| EP-4653448-A1 | COMPOUND FOR RNA CAPPING AND USE THEREOF | Guangzhou Henovcom Bioscience Co. Ltd. (CN) | 2025-11-26 | — | — | EP | claimed |
| US-12359071-B2 | Polymeric tandem dyes with linker groups | Sony Group Corporation (JP) | 2025-07-15 | — | — | US | claimed |
| US-20250197523-A1 | ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE | 2SEVENTY BIO, INC. | 2025-06-19 | — | — | US | claimed |
| CN-120040596-A | Anti-idiotype antibody and application thereof | 重庆精准生物技术有限公司 | 2025-05-27 | — | — | CN | claimed |
| WO-2025082165-A1 | CELL VIABILITY TESTING METHOD, INDICATOR AND USE THEREOF | 重庆精准生物产业技术研究院有限公司 | 2025-04-24 | — | — | WO | claimed |
| US-20220380603-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | SONY GROUP CORP (JP) | 2022-12-01 | — | — | US | claimed |
| EP-4076522-A1 | ANTI-BCMA CAR ANTIBODIES, CONJUGATES, AND METHODS OF USE | 2seventy bio, Inc. (US) | 2022-10-26 | — | — | EP | claimed |
| CN-115066611-A | Multiplex immunofluorescence detection of target antigens | 奥克兰联合服务有限公司 | 2022-09-16 | — | — | CN | claimed |
| WO-2022140344-A9 | DIFFUSION GRADIENT ASSAY FOR ANTI-CD3-CONTAINING MOLECULES | AMGEN INC. (US) | 2022-09-09 | — | — | WO | claimed |
| CN-114929277-A | anti-BCMA CAR antibodies, conjugates, and methods of use | 2赛文缇生物公司 | 2022-08-19 | — | — | CN | claimed |
| WO-2022140344-A1 | DIFFUSION GRADIENT ASSAY FOR ANTI-CD3-CONTAINING MOLECULES | AMGEN INC. (US) | 2022-06-30 | — | — | WO | claimed |
| US-11352502-B2 | Polymeric tandem dyes with linker groups | Sony Group Corporation (JP) | 2022-06-07 | — | — | US | claimed |
| WO-2022109339-A1 | USE OF DEXTRAMER IN SINGLE CELL ANALYSIS | BECTON, DICKINSON AND COMPANY (US) | 2022-05-27 | — | — | WO | claimed |
| CN-114487415-A | Tumor cell PD-L1PD-L2 immunofluorescence + FISH detection kit | 江苏莱尔生物医药科技有限公司 | 2022-05-13 | — | — | CN | claimed |
| US-20220064226-A1 | Panel comprising Borrelia MHC multimers | IMMUDEX APS (DK) | 2022-03-03 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11352502-B2 | Polymeric tandem dyes with linker groups | CHRM1, IK, TMT1A | HTR1A 866/4885HRH3 484/4885SIRT2 2471/4885 |
| US-20220380603-A1 | POLYMERIC TANDEM DYES WITH LINKER GROUPS | CHRM1, IK, TMT1A | HTR1A 866/4885HRH3 484/4885SIRT2 2471/4885 |
| US-12359071-B2 | Polymeric tandem dyes with linker groups | CHRM1, IK, TMT1A | HTR1A 866/4885HRH3 484/4885SIRT2 2471/4885 |
| US-12545746-B2 | Anti-BCMA car antibodies, conjugates, and methods of use | CD47, RBM25, CD22 | HTR1A 4597/4885HRH3 2985/4885SIRT2 3599/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.